首页> 外文期刊>BMC Health Services Research >Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories
【24h】

Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories

机译:日本医院感染监测(JANIS):基于医院诊断微生物实验室的可持续国家抗微生物药物耐药性监测模型

获取原文
           

摘要

Antimicrobial resistance (AMR) is now recognized as a major threat to public health, and surveillance of AMR is essential for successful containment. In 2000, Japan Nosocomial Infections Surveillance (JANIS) Clinical Laboratory (CL) division has been launched as a voluntary AMR surveillance funded by the Ministry of Health, Labour and Welfare and managed by the National Institute of Infectious Diseases. In this study, we aimed to propose a model of sustainable national AMR surveillance which provides not only national AMR surveillance reports but also benchmarking reports to each hospital to facilitate infection control practices. JANIS CL division collects comprehensive specimen-based data complies with JANIS data format from participating hospitals each month. It had targeted only blood and cerebrospinal fluid samples but was expanded to all types of specimens in 2007 at revision of JANIS. The JANIS system interprets the antimicrobial susceptibility according to the same criteria and conducts removal of duplicates to allow accurate comparison between hospitals. Monthly feedback reports are created automatically within 48?h, while quarterly and annual reports are generated after data validation. At the beginning, 468 hospitals were enrolled in the JANIS CL division, but the number of hospitals that submitted data decreased to 210 (45%) in 2006. After surveillance revision in 2007, annual recruitment of hospitals was initiated and as of 2015, 1475 hospitals participated, and 1461 (99%) of them submitted data throughout the year. Nationwide surveillance data collected over the past decade revealed that the prevalence of methicillin-resistant Staphylococcus aureus has decreased since 2008, and that its prevalence is higher in the western part of Japan, where the number of hospitals per capita is higher than in the eastern part. JANIS CL division serves a model of sustainable national AMR surveillance system. Comprehensive data for all specimens promotes understanding of the sampling frequency and prevalence of AMR. As a well-established system for providing rich information to guide action both locally and nationally, JANIS may also be utilized for sharing AMR data globally.
机译:抗菌素耐药性(AMR)现在被认为是对公共健康的主要威胁,对AMR的监视对于成功遏制至关重要。 2000年,日本医院感染监测(JANIS)临床实验室(CL)部门成立,作为由厚生劳动省资助,由国立传染病研究所管理的自愿性AMR监测。在这项研究中,我们旨在提出一种可持续的国家AMR监测模型,该模型不仅提供国家AMR监测报告,而且还向每家医院提供基准报告,以促进感染控制实践。 JANIS CL部门每月从参加活动的医院收集符合JANIS数据格式的综合标本数据。它仅针对血液和脑脊液样本,但在2007年JANIS修订版中扩展到了所有类型的样本。 JANIS系统根据相同的标准解释抗菌药的敏感性,并去除重复样本,以实现医院之间的准确比较。每月反馈报告将在48小时内自动创建,而季度和年度报告则在数据验证后生成。最初,有468家医院加入了JANIS CL部门,但是提交数据的医院数量在2006年减少到210家(占45%)。在2007年进行监视修订之后,开始了每年的医院招募工作,截至2015年,为1475家医院参加了调查,其中1461个(99%)全年提交了数据。过去十年收集的全国性监测数据显示,耐甲氧西林金黄色葡萄球菌的流行率自2008年以来有所下降,并且其流行率在日本西部较高,日本的人均医院数量高于东部。 JANIS CL部门为可持续的国家AMR监视系统提供了模型。所有标本的综合数据可促进对AMR采样频率和患病率的了解。作为一种成熟的系统,它可以提供丰富的信息来指导本地和全国性的行动,JANIS也可以用于在全球范围内共享AMR数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号